• Explore /
  • Poster
  • / Multivariate analysis of factors affecting overall survival, event free survival, and 60-day mortality among AML patients treated with CPX-351 or intensive chemotherapy.

Multivariate analysis of factors affecting overall survival, event free survival, and 60-day mortality among AML patients treated with CPX-351 or intensive chemotherapy.

Abstract Poster

Authors

null

Eric Jay Feldman

Weill Cornell Medical College, New York, NY

Eric Jay Feldman , Jeffrey E. Lancet , Jonathan E. Kolitz , Donna Hogge , Martin S. Tallman , Stuart L. Goldberg , Tibor Kovacsovics , Arthur Chin Louie , Jorge E. Cortes

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Leukemia, Myelodysplasia, and Transplantation

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Leukemia

Clinical Trial Registration Number

NCT00788892 and NCT00822094

Citation

J Clin Oncol 31, 2013 (suppl; abstr 7100)

DOI

10.1200/jco.2013.31.15_suppl.7100

Abstract #

7100

Poster Bd #

42D

Abstract Disclosures

Similar Posters

First Author: Geoffrey L. Uy

First Author: Jeffrey E. Lancet

First Author: Jeffrey E. Lancet

First Author: Richard M. Stone